Rapid and Sensitive Detection of Staphylococcal Enterotoxin B by Recombinant Nanobody Using Phage Display Technology
- 305 Downloads
Staphylococcal enterotoxin B, from Staphylococcus aureus (S. aureus), is one of the most potent bacterial superantigens with profound toxic effects on the immune system. It is associated with food poisoning, toxic shock, atopic dermatitis, asthma, and nasal polyps in humans. The current diagnostic methods for staphylococcal enterotoxin are mainly based on traditional monoclonal antibodies which hardly meet the requirements for clinical applications, and hybridoma clones lose their ability to secrete antibodies during time. The present study investigates the development of a novel, highly specific, low-cost, and sensitive nanobody capable of being used in immunoassays for Staphylococcal enterotoxin B (SEB) detection in suspicious foods. For this purpose, Camelus dromedarius was immunized against SEB toxin. After obtaining acceptable titration, a high-quality phage display nanobody library (4 × 1010 PFU/ml) was constructed. High-affinity SEB-specific nanobodies were retrieved from constructed libraries. After phage rescue and five round of biopanning, clone screening was performed by phage ELISA. Recombinant nanobodies which were expressed from C7 and C21 clone showed the highest affinity for SEB. The presence of high quality and pure nanobody band at ~ 15 kDa was confirmed by SDS-PAGE and western blotting. The affinity constant which was measured by ELISA was calculated to be around 10−9 M. The results suggest that the proposed detection method by nanobodies is an alternative diagnostic tool enabling a rapid, inexpensive, and specific detection of the SEB.
KeywordsCamel Nanobody Single-domain antibody Phage display VHH Staphylococcal enterotoxin B
Camelid heavy chain antibody
Enzyme-linked immunoabsorbent immunoassay
Heavy chain antibodies
Staphylococcal enterotoxin B
Sodium dodecyl sulfate polyacryl amide gel electrophoresis
The authors would like to thank the research council of Malek-Ashtar University of Technology for the financial support of this investigation.
Compliance with Ethical Standards
Conflict of Interest
The authors declare no conflict of interest.
- 4.Hennekinne, J.-A., Brun, V., De Buyser, M.-L., Dupuis, A., Ostyn, A., & Dragacci, S. (2009). Innovative application of mass spectrometry for the characterization of staphylococcal enterotoxins involved in food poisoning outbreaks. Applied and Environmental Microbiology, 75(3), 882–884.CrossRefGoogle Scholar
- 5.Koluman, A., Unlu, T., Dikici, A., Tezel, A., Akcelik, E. N., & Burkan, Z. T. (2011). Presence of Staphylococcus aureus and staphylococcal enterotoxins in different foods. Kafkas Üniversitesi Veteriner Fakültesi Dergisi, 17(Suppl A), 55–60.Google Scholar
- 7.Vasconcelos, N. G., & Ribeiro de Souza da Cunha, M. L. (2010). Staphylococcal enterotoxins: molecular aspects and detection methods. Journal of Public Health and Epidemiology, 2(3), 29–42.Google Scholar
- 20.Ebrahimizadeh, W., Gargari, S. M., Rajabibazl, M., Ardekani, L. S., Zare, H., & Bakherad, H. (2013). Isolation and characterization of protective anti-LPS nanobody against V. Cholerae O1 recognizing Inaba and Ogawa serotypes. Applied Microbiology and Biotechnology, 97(10), 4457–4466.CrossRefGoogle Scholar
- 25.Acharya, S., Shukla, S., Mahajan, S., & Diwan, S. (2011). The charisma of “magic bullets”–monoclonal antibodies (mAB/moAB) in clinical medicine. Journal of the Indian Academy of Clinical Medicine, 12(4), 283–289.Google Scholar
- 27.Dübel, S., & Reichert, J. M. (2014). Handbook of therapeutic antibodies. Weinheim: John Wiley & Sons.Google Scholar